In a recent statement, Haynes and Boone LLP announced the hiring of a new life sciences attorney, previously counseled by Rothwell Figg Ernst & Manbeck PC. The attorney will focus on biotechnology and pharmaceutical intellectual property matters. This move is part of Haynes and Boone’s ongoing commitment to expanding their expertise in key sectors.
Roping in the experienced attorney from Rothwell Figg shows a strategic move on Haynes and Boone’s part. As such, it underlines the firm’s ongoing expansion within the life sciences sector. The new addition is expected to bring invaluable insights and strategies related to biotechnology and pharmaceutical intellectual property matters. This will undoubtedly reinforce the firm’s position on such matters, enabling them to offer an even broader scope of guidance to their clients operating in the life sciences industry.
Bringing this kind of talent on board proves how Haynes and Boone intends to further strengthen its foothold in life sciences intellectual property law. The unique expertise that the new attorney brings to the table is certain to serve the complex needs of clients in this demanding industry.
For more detailed coverage of this development, the initial report is available on Law360.